Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
$-0.19 → $-0.19 · observed estimates
Douglas Elliman, Inc. (DOUG)
NYSEReal EstateReal Estate - ServicesSnapshot 2026-11-04
$1.57-5.99%
Close 2026-11-05 · 1-day change
NYSEReal EstateReal Estate - ServicesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for DOUG yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Positive cash flow from operations | Management aims to turn negative cash flow from operations of -$19.3M positive. | Improving | cash flow from operations remains negative next 4 quarters | Cash from operations: $11.603M FY2026-Q2; GAAP. Published target: cash flow from operations turns positive next 4 quarters. Target period is not explicitly aligned with this observation. Aug 10, 202611,603,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
$-0.19 → $-0.19 · observed estimates
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a higher-risk, rate-sensitive real estate business with a developing recovery case, not yet a proven durable compounder. The multi-year view is on watch because recent performance has lagged its industry cohort, while improving cash flow offers some support.
The evidence describes DOUG as cheap versus peers, with a negative expectations gap, meaning market expectations appear subdued. The priced-in assessment is justified and fragility is low, but that does not resolve the business’s loss-making status or elevated risk.
Near term, results may remain uneven: comparable revenue grew 8.6% year over year in 2026-Q2, while Q1 revenue fell against a strong prior-year quarter. Operating loss narrowed and cash from operations turned positive in Q2, supporting management’s stated focus on cash flow, though a smaller-company base rate and erratic earnings surprises make the next report worth watching.
Over the next year, sustained revenue growth and positive operating cash flow would strengthen the case that expense discipline and expansion are delivering. Fed rate cuts could support rate-sensitive real estate businesses, while guidance cuts or weaker results from sector peers could remove support; the evidence does not establish which scenario will occur.
For the 1-3 year view, DOUG combines subdued expectations with early cash-flow progress, but its loss-making profile, uneven results, and elevated risk keep the thesis conditional on execution. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in Douglas Elliman, Inc.'s published investment case. The stated target is no major negative management or legal events next 4 quarters. |
| Under Pressure |
| new significant legal or management issues arise |
1 major legal event vs 0 target Oct 2026 news reports broker fired after racial discrimination allegations, creating new legal risk. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth reverses decline and stabilizes | A primary condition in Douglas Elliman, Inc.'s published investment case. The stated target is revenue stabilizes or grows to at least $214M next 4 quarters. | Intact | revenue falls below $214M next 4 quarters | Revenue: $283.449M FY2026-Q2; GAAP. Published target: revenue stabilizes or grows to at least $214M next 4 quarters. Target period is not explicitly aligned with this observation. Aug 10, 2026283,449,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.11B → $1.11B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-10-15 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-16 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-17 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-18 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-19 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-20 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-21 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-22 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-23 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-24 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-25 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-26 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-27 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-28 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-29 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-30 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-10-31 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-11-01 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-11-02 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-11-03 | $-0.19 | $1,111,800,000 | 1 / 1 |
| 2026-11-04 | $-0.19 | $1,111,800,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.